Copaxone®
Manufacturer: Teva
Indications: Copaxone
® is indicated for reduction of the frequency of relapses in patients with Relapsing-Remitting Multiple Sclerosis (RRMS), including patients who have experienced a first clinical episode and have MRI features consistent with multiple sclerosis.
For indications, dosing and other information, please refer to the manufacture package insert.
| Product |
Size |
NDC |
PI |
MSDS |
|
Copaxone® |
1mL Pre-filled syringe |
68546-0317-30 |
PI |
MSDS |
Clinical Data: For any Questions or for further information related to
Copaxone
®, Intravenous Immune Globulin (Human) clinical pharmacology, additional indications and usages, contraindications, warnings, precautions, adverse reations, dosage, administration and/or storage of this product, please
contact BDI Pharma or call 1-800-948-9834